Recent Work Merrion
Share This

Merrion

Friday, 07 November 2008

Advised Merrion on their license agreement with Novo Nordisk to develop and commercialise oral formulations of Novo Nordisk’s proprietary Insulin analogues, using Merrion’s proprietary GIPET® technology.